A Study of Ramucirumab (LY3009806) Plus MEDI4736 in Participants With Advanced Gastrointestinal or Thoracic Malignancies

Clinical trial NCT02572687 · COMPLETED

Trial details

NCT number: NCT02572687
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Gastric Cancer Gastroesophageal Junction Adenocarcinoma Non-Small Cell Lung Cancer Hepatocellular Carcinoma

Start date: 2016-02-19
Primary completion: 2018-03-27
Enrollment: 85

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.